References
- Bang N U, Kammer R B. Hematologic complications associated with beta-lactam antibiotics. Rev Infect Dis 1983; 5: S380–S393
- Fass R J, Copelan E A, Brandt J T, Moeschberger M L, Ashton J. Platelet-mediated bleeding caused by broad-spectrum penicillins. Rev Infect Dis 1987; 155: 1242–1248
- Gentry L O, Jemsek J G, Natelson E A. Effects of sodium piperacillin on platelet function in normal volunteers. Antimicrob Agents Chemother 1981; 19: 532–533
- Somani P, Smith M R, Gohara A, Kapila K. The effects of mezlocillin, ticarcillin and placebo on blood coagulation and bleeding time in normal volunteers. J Antimicrob Chemother 1983; 11(Suppl C)33–41
- Gooding P C, Clark B J, Sathe S S. Piperacillin: A review of clinical experience. J Antimicrob Chemother 1982; 9(Suppl B)93–99
- Bressler R B, Huston D P. Piperacillin - induced anemia and leukopenia. South Med J 1986; 79: 255–256
- Lang R, Lishner M, Ravid M. Adverse reactions to prolonged treatment with high doses of carbenicillin and ureidopenicillins. Rev Infect Dis 1991; 13: 68–72
- Christie D J, Lennon S S, Drew R L, Swinehart C D. Cefotetan-induced immunological thrombocytopenia. Br J Haematol 1988; 70: 423–426
- Gralnick H R, McGinniss M, Halterman R. Thrombocytopenia with sodium cephalothin therapy. Ann Intern Med 1972; 77: 401–404
- Choo P W, Gantz N M. Reversible leukopenia related to ciprofloxacin therapy. South Med J 1990; 83: 597–598
- Ball P. Ciprofloxacin: An overview of adverse experience. J Antimicrob Chemother 1986; 18(Suppl D)187–193